U.S. flag An official website of the United States government
  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. CPG Sec. 651.100 Ethylenediamine Dihydroiodide (EDDI)
  1. Regulatory Information

COMPLIANCE POLICY GUIDE (CPG)

CPG Sec. 651.100 Ethylenediamine Dihydroiodide (EDDI) June 2019

Final

CPG Sec. 651.100 Ethylenediamine Dihydroiodide (EDDI)

Issued by:
Guidance Issuing Office
Center for Veterinary Medicine
Office of Regulatory Affairs

This guidance document represents the Agency's current thinking on animal products containing ethylenediamine dihydroiodide (EDDI) or feeds containing unapproved new drugs under the provisions of the Federal Food, Drug, and Cosmetic Act (the FD&C Act).


Submit Comments

Submit comments on this guidance document electronically via docket ID: FDA-2013-S-0610 - Specific Electronic Submissions Intended For FDA's Dockets Management Staff (i.e., Citizen Petitions, Draft Proposed Guidance Documents, Variances, and other administrative record submissions)

If unable to submit comments online, please mail written comments to:

Division of Dockets Management (HFA- 305)
Food and Drug Administration
5630 Fishers Lane, Rm. 1061
Rockville, MD 20852

All comments should be identified with the title of the guidance.

Questions?

Contact Point
CVM
Center for Veterinary Medicine
Food and Drug Administration
7500 Standish Pl, HFV-1
Rockville, MD 20855
AskCVM@fda.hhs.gov
(240) 402-7002